Literature DB >> 30500074

Leukemia therapy by flavonoids: Future and involved mechanisms.

Raedeh Saraei1,2,3, Faroogh Marofi1,2, Adel Naimi2, Mehdi Talebi1,3, Mahnaz Ghaebi4, Naser Javan5, Omid Salimi6, Ali Hassanzadeh2,3.   

Abstract

Flavonoids are a varied family of phytonutrients (plant chemicals) usually are detected in fruits and vegetables. In this big family, there exist more than 10,000 members that is separated into six chief subtypes: isoflavonols, flavonoenes, flavones, flavonols, anthocyanins, and chalcones. The natural compounds, such as fruits, have visible positive effects in regulating of survival involved signaling pathways that performance as the regulator of cell survival, growth, and proliferation. Researchers have established that commonly consumption up flavonoids decreases incidence and development risk of certain cancers, especially leukemia. Flavonoids have been able to induce apoptosis and stimulate cell cycle arrest in cancer cells via different pathways. Similarly, they have antiangiogenesis and antimetastasis capability, which were shown in wide ranges of cancer cells, particularly, leukemia. It seems that flavonoid because of their widespread approval, evident safety and low rate of side effects, have hopeful anticarcinogenic potential for leukemia therapy. Based on the last decade reports, the most important acting mechanisms of these natural compounds in leukemia cells are stimulating of apoptosis pathways by upregulation of caspase 3, 8, 9 and poly ADP-ribose polymerase (PARP) and proapoptotic proteins, particularly Bax activation. As well, they can induce cell cycle arrest in target cells not only via increasing of activated levels of p21 and p53 but also by inhibition of cyclins and cyclin-dependent kinases. Furthermore, attenuation of neclear factor-κB and signal transducer and activator of transcription 3 activation, suppression of signaling pathway and downregulation of intracellular antiapoptotic proteins are other significant antileukemic function mechanism of flavonoids. Overall, it appears that flavonoids are promising and effective compounds in the field of leukemia therapy. In this review, we tried to accumulate and revise most promising flavonoids and finally declared their major working mechanisms in leukemia cells.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Apoptosis; CDKs and Caspase 3, 8, and 9; Flavonoids; NF-kB; STAT3; VEGF/HSP27; leukemia; p21/53

Mesh:

Substances:

Year:  2018        PMID: 30500074     DOI: 10.1002/jcp.27628

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents.

Authors:  Hidetomo Kikuchi; Bo Yuan; Xiaomei Hu; Mari Okazaki
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

2.  Cytotoxic and Apoptotic Effects of Luffa Cylindrica Leaves Extract against Acute Lymphoblastic Leukemic Stem Cells.

Authors:  Shimaa Yehia; Ibrahim M Abdel-Salam; Basma M Elgamal; Basma El-Agamy; Germine M Hamdy; Hala M Aldouski
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

3.  Ampelopsin Inhibits Cell Proliferation and Induces Apoptosis in HL60 and K562 Leukemia Cells by Downregulating AKT and NF-κB Signaling Pathways.

Authors:  Jang Mi Han; Hong Lae Kim; Hye Jin Jung
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 4.  The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics.

Authors:  Elham Zeinalzadeh; Alexey Valerievich Yumashev; Heshu Sulaiman Rahman; Faroogh Marofi; Navid Shomali; Hossein Samadi Kafil; Saeed Solali; Mehdi Sajjadi-Dokht; Sajjad Vakili-Samiani; Mostafa Jarahian; Majid Farshdousti Hagh
Journal:  Front Genet       Date:  2021-12-21       Impact factor: 4.599

5.  Caspase-3/NLRP3 signaling in the mesenchymal stromal niche regulates myeloid-biased hematopoiesis.

Authors:  Jing Zhang; Yaozhen Chen; Dandan Yin; Fan Feng; Qunxing An; Zhixin Liu; Ning An; Jinmei Xu; Jing Yi; Shunli Gu; Wen Yin; Yazhou Wang; Xingbin Hu
Journal:  Stem Cell Res Ther       Date:  2021-11-20       Impact factor: 6.832

6.  Studies Regarding the Pharmaceutical Potential of Derivative Products from Plantain.

Authors:  Marilena-Gabriela Olteanu Zaharie; Nicoleta Radu; Lucia Pirvu; Marinela Bostan; Mariana Voicescu; Mihaela Begea; Mariana Constantin; Catalina Voaides; Narcisa Babeanu; Viviana Roman
Journal:  Plants (Basel)       Date:  2022-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.